SCHEMBL30824482

SCHEMBL30824482

COc1ncc2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
TLR8 Q9NR97 1/20 0.43
CYP1A2 P05177 6/20 0.42
HTR3A P46098 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
GPR3 P46089 1/20 0.42
EGFR P00533 1/20 0.42
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
NQO2 P16083 2/20 0.41
POLB P06746 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382006 1.00 KDM4E (0.46) KDM4ETLR8CYP1A2HTR3AHRH4
Hydrochloric Acid SCHEMBL28102802 0.98 KDM4E (0.44) KDM4ETLR8CYP1A2HTR3AHRH4
Hydrochloric Acid SCHEMBL28174209 0.98 KDM4E (0.44) KDM4ETLR8CYP1A2HTR3AHRH4
SCHEMBL3277330 0.83 KDM4E (0.45) KDM4ECYP1A2HTR3AHRH4GPR3
SCHEMBL27825404 0.81 CYP1A2 (0.38) KDM4ETLR8CYP1A2HTR3AHRH4
SCHEMBL28624806 0.80 CYP1A2 (0.40) KDM4ETLR8CYP1A2HTR3AHRH4
SCHEMBL3634933 0.80 TLR8 (0.49) KDM4ETLR8CYP1A2HTR3AHRH4
SCHEMBL30952029 0.80 TLR8 (0.49) KDM4ETLR8CYP1A2HTR3AHRH4
SCHEMBL716117 0.80 TSHR (0.50) KDM4ETLR8CYP1A2HTR3AHRH4
SCHEMBL5004880 0.79 TLR8 (0.47) KDM4ETLR8CYP1A2HTR3AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067632-A1 WEE1 Degrading Compounds and Uses Thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2024-02-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067632-A1 WEE1 Degrading Compounds and Uses Thereof WEE1, WEE2, PPME1 KDM4E 376/4885TLR8 3951/4885CYP1A2 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.